|
|
|
|
| LEADER |
05115nma a2201465 u 4500 |
| 001 |
EB002195101 |
| 003 |
EBX01000000000000001332566 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
240202 ||| eng |
| 020 |
|
|
|a books978-3-0365-9449-1
|
| 020 |
|
|
|a 9783036594491
|
| 020 |
|
|
|a 9783036594484
|
| 100 |
1 |
|
|a Gallinella, Giorgio
|
| 245 |
0 |
0 |
|a Advances in Parvovirus Research 2022
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (288 p.)
|
| 653 |
|
|
|a Africa
|
| 653 |
|
|
|a simian erythroparvovirus
|
| 653 |
|
|
|a conference report
|
| 653 |
|
|
|a AMDV
|
| 653 |
|
|
|a serotype
|
| 653 |
|
|
|a next generation sequencing
|
| 653 |
|
|
|a paleovirology
|
| 653 |
|
|
|a parvovirus
|
| 653 |
|
|
|a genotype
|
| 653 |
|
|
|a oncolytic virus immunotherapy
|
| 653 |
|
|
|a AAV
|
| 653 |
|
|
|a galectin-1
|
| 653 |
|
|
|a Epidemiology and Medical statistics / bicssc
|
| 653 |
|
|
|a pig-tailed erythroparvovirus
|
| 653 |
|
|
|a endogenous viral elements
|
| 653 |
|
|
|a laminin γ1
|
| 653 |
|
|
|a functional complementation
|
| 653 |
|
|
|a recombination
|
| 653 |
|
|
|a porcine parvovirus
|
| 653 |
|
|
|a Next Generation Sequencing
|
| 653 |
|
|
|a receptor
|
| 653 |
|
|
|a hereditary spherocytosis
|
| 653 |
|
|
|a replicon unit
|
| 653 |
|
|
|a oncolytic virus
|
| 653 |
|
|
|a intraspecies
|
| 653 |
|
|
|a virus cell entry
|
| 653 |
|
|
|a Amdoparvovirus
|
| 653 |
|
|
|a protoparvovirus H-1PV
|
| 653 |
|
|
|a cancer
|
| 653 |
|
|
|a Parvovirus B19
|
| 653 |
|
|
|a tropism
|
| 653 |
|
|
|a VP1u
|
| 653 |
|
|
|a I-ELISA
|
| 653 |
|
|
|a genetic engineering
|
| 653 |
|
|
|a porcine parvovirus 1
|
| 653 |
|
|
|a evolution
|
| 653 |
|
|
|a acute infection
|
| 653 |
|
|
|a hemolysis
|
| 653 |
|
|
|a Shannon Entropy
|
| 653 |
|
|
|a viral DNA load
|
| 653 |
|
|
|a canine parvovirus type 2
|
| 653 |
|
|
|a virus surveillance
|
| 653 |
|
|
|a epidemiology
|
| 653 |
|
|
|a Parvoviridae
|
| 653 |
|
|
|a parvoviruses
|
| 653 |
|
|
|a H1-PV
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a viral quasispecies
|
| 653 |
|
|
|a RBoV
|
| 653 |
|
|
|a persistent infection
|
| 653 |
|
|
|a phylogeny
|
| 653 |
|
|
|a molecular epidemiology
|
| 653 |
|
|
|a synthetic genome
|
| 653 |
|
|
|a genetic diversity
|
| 653 |
|
|
|a Minute Virus of Mice
|
| 653 |
|
|
|a parvovirus B19
|
| 653 |
|
|
|a immunity
|
| 653 |
|
|
|a Benzonase®
|
| 653 |
|
|
|a illegal trade
|
| 653 |
|
|
|a FPV
|
| 653 |
|
|
|a cryo-EM
|
| 653 |
|
|
|a pathogen
|
| 653 |
|
|
|a pairwise genetic distance
|
| 653 |
|
|
|a anticancer gene
|
| 653 |
|
|
|a Tetraparvovirus
|
| 653 |
|
|
|a adeno-associated virus
|
| 653 |
|
|
|a virus-like particles
|
| 653 |
|
|
|a infection
|
| 653 |
|
|
|a VP1uR
|
| 653 |
|
|
|a phylogeography
|
| 653 |
|
|
|a cancer gene therapy
|
| 653 |
|
|
|a skunk amdoparvovirus
|
| 653 |
|
|
|a bocavirus
|
| 653 |
|
|
|a wildlife
|
| 653 |
|
|
|a CnMV
|
| 653 |
|
|
|a rhesus erythroparvovirus
|
| 653 |
|
|
|a PARV4
|
| 653 |
|
|
|a capsid
|
| 653 |
|
|
|a PBoV
|
| 653 |
|
|
|a international workshop
|
| 653 |
|
|
|a virus evolution
|
| 653 |
|
|
|a VP2
|
| 653 |
|
|
|a diagnostic
|
| 653 |
|
|
|a HIV infection
|
| 653 |
|
|
|a classification
|
| 653 |
|
|
|a spillover
|
| 653 |
|
|
|a cluster analysis
|
| 653 |
|
|
|a DNA damage response
|
| 653 |
|
|
|a virus host interactions
|
| 653 |
|
|
|a striped skunk
|
| 653 |
|
|
|a companion animals
|
| 653 |
|
|
|a B19V
|
| 653 |
|
|
|a Protoparvovirus carnivoran1
|
| 653 |
|
|
|a CPV-2
|
| 653 |
|
|
|a primate erythroparvovirus
|
| 700 |
1 |
|
|a Gallinella, Giorgio
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-0365-9449-1
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/128799
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/8266
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 576
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 380
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 620
|
| 520 |
|
|
|a Viruses in the Parvoviridae family constitutes a most diverse and intriguing field of research. Parvoviruses have a long evolutionary history and, beneath an apparent simplicity and uniformity, can differ widely in structure, genome organization and expression, virus-cell interaction, and impact on the host. In addition to interest in the study of basic virology, the translational implications of research on parvoviruses are relevant since many viruses are important human and veterinary pathogens, while other viruses can be engineered as tools for oncolytic therapy or as sophisticated gene delivery vectors. Exploring the diversity and the inherent complexity in the biology of these apparently simple viruses is an ongoing commitment for the scientific community to address. This Special Issue entitled 'Advances in Parvovirus Research 2022' continued the series dedicated to research on viruses belonging to the Parvoviridae family and collected the latest contributions in the field of parvovirus research.
|